Add Company
Join Now

MyMD Pharmaceuticals Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Pharma

Industry

Employee Data

  • MyMD Pharmaceuticals has 11 Employees.(i)
  • MyMD Pharmaceuticals grew their employee count by 0% last year.

MyMD Pharmaceuticals's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7M26-10%N/AN/A
#2
N/A110%N/AN/A
#3
$7.2M28-7%N/AN/A
#4
$10.5M24-44%N/AN/A
#5
$344.1M166718%N/AN/A
#6
$27.5M1239%N/AN/A
#7
$107.3M52419%N/AN/A
#8
$12.9M6428%N/AN/A
#9
$31.6M1454%N/AN/A
#10
$31.4M125-3%N/AN/A
Add Company

What Is MyMD Pharmaceuticals?

MyMD is a clinical stage biotech pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms. MYMD-1 is a drug platform based on a clinical stage small molecule that regulates the immunometabolic system to control tumor necrosis factor alpha (TNF-α) and other pro-inflammatory cytokines. MYMD-1 is being developed to treat autoimmune diseases, including those currently treated with non-selective TNF-α blocking drugs, and aging and longevity. Supera-CBD is a drug platform based on a novel (patent pending) synthetic derivative of cannabidiol (CBD) that targets numerous key receptors including CB2 and opioid receptors and inhibits monoamine oxidase. Supera-CBD is being developed to address the rapidly growing CBD market that includes FDA approved drugs and CBD products not currently regulated as a drug.

keywords:N/A

N/A

Total Funding

11

Number of Employees

N/A

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.4M1183%N/A
#2
$4M11-15%N/A
#3
$1.1M1183%N/A
#4
$1M110%N/A
#5
$1M11N/AN/A